3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
NIH
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
1
Interventions
Specimen Handling
7
Magnetic Resonance Spectroscopy
7
Radiotherapy
5
Biopsy
4
Radiation
3
High-Energy Shock Waves
3
Cyclophosphamide
3
venetoclax
2
X-Rays
2
Vincristine
2
Spinal Puncture
2
Sentinel Lymph Node Biopsy
2
Radiosurgery
2
Paclitaxel
2
Daunorubicin
2
Cytarabine
2
Azacitidine
2
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
taxane
1
sulforaphane
1
sacituzumab govitecan
1
revumenib
1
prednylidene
1
pertuzumab
1
pembrolizumab
1
pegaspargase
1
nelarabine
1
merphos
1
liposomal doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
NETWORK
×
CPX-351
×
Clear all
NCT05628623
2024-07-03
ERASE
Eastern Cooperative Oncology Group
Phase 2
Not yet recruiting
184 enrolled